Lunai Bioworks Unveils Parkinson’s Subtypes to Target Drug Development
Lunai Bioworks, an AI-driven biotechnology company based in Sacramento, has identified three clinically relevant subtypes of Parkinson’s disease along with prioritized drug targets. This development aims to enhance proof-of-concept programs…